Methodological considerations in assessing GLP-1 receptor agonists and gastrointestinal cancer risk

JAMES CHENG-CHUNG WEI2026-10-162026-10-162024-12-01Pure ID: 14933334Pure UUID: 76d49fa4-28cc-4d11-8fdd-3de272c7786710.1016/j.phrs.2024.107481https://www.scopus.com/pages/publications/85207799469https://scholars.csmu.edu.tw/handle/123456789/29414enMethodological considerations in assessing GLP-1 receptor agonists and gastrointestinal cancer riskjournal article